Style | Citing Format |
---|---|
MLA | Miratashi Yazdi SA, et al.. "Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study." International Journal of Surgery Open, vol. 46, no. , 2022, pp. -. |
APA | Miratashi Yazdi SA, Bakhshi N, Nazar E, Moradi Tabriz H, Gorji R (2022). Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study. International Journal of Surgery Open, 46(), -. |
Chicago | Miratashi Yazdi SA, Bakhshi N, Nazar E, Moradi Tabriz H, Gorji R. "Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study." International Journal of Surgery Open 46, no. (2022): -. |
Harvard | Miratashi Yazdi SA et al. (2022) 'Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study', International Journal of Surgery Open, 46(), pp. -. |
Vancouver | Miratashi Yazdi SA, Bakhshi N, Nazar E, Moradi Tabriz H, Gorji R. Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study. International Journal of Surgery Open. 2022;46():-. |
BibTex | @article{ author = {Miratashi Yazdi SA and Bakhshi N and Nazar E and Moradi Tabriz H and Gorji R}, title = {Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study}, journal = {International Journal of Surgery Open}, volume = {46}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Miratashi Yazdi SA AU - Bakhshi N AU - Nazar E AU - Moradi Tabriz H AU - Gorji R TI - Epidermal Growth Factor Receptor (Egfr) Expression in High Grade Glioma and Relationship With Histopathologic Findings, a Cross Sectional Study JO - International Journal of Surgery Open VL - 46 IS - SP - EP - PY - 2022 ER - |